DK0828488T3 - Isothiazoloner - Google Patents

Isothiazoloner

Info

Publication number: DK0828488T3
Authority: DK; Denmark
Prior art keywords: isothiazolones
Prior art date: 1995-05-31

Application number

DK96913177T

Other languages

Danish (da)

English (en)

Inventor

Bharat Kalidas Trivedi

Gary Louis Bolton

John Michael Domagala

Edward Faith Elslager

Rocco Dean Gogliotti

Terri Stoeber Purchase

Joseph Peter Sanchez

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-31

Filing date

1996-04-26

Publication date

2003-05-19

1996-04-26 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-05-19 Application granted granted Critical

2003-05-19 Publication of DK0828488T3 publication Critical patent/DK0828488T3/da

Links

JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical class O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK96913177T 1995-05-31 1996-04-26 Isothiazoloner DK0828488T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/456,149 US5620997A (en)	1995-05-31	1995-05-31	Isothiazolones
PCT/US1996/005821 WO1996038144A1 (en)	1995-05-31	1996-04-26	Isothiazolones

Publications (1)

Publication Number	Publication Date
DK0828488T3 true DK0828488T3 (da)	2003-05-19

Family

ID=23811632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96913177T DK0828488T3 (da)	1995-05-31	1996-04-26	Isothiazoloner

Country Status (37)

Country	Link
US (4)	US5620997A (de)
EP (1)	EP0828488B1 (de)
JP (1)	JP2002502353A (de)
KR (2)	KR19990022132A (de)
CN (1)	CN1114402C (de)
AR (1)	AR002740A1 (de)
AT (1)	ATE232385T1 (de)
AU (1)	AU723233B2 (de)
BG (1)	BG62792B1 (de)
CA (1)	CA2218253A1 (de)
CO (1)	CO4700292A1 (de)
CZ (1)	CZ373997A3 (de)
DE (1)	DE69626203T2 (de)
DK (1)	DK0828488T3 (de)
EA (1)	EA000898B1 (de)
EE (1)	EE9700287A (de)
ES (1)	ES2192224T3 (de)
GE (1)	GEP20012375B (de)
GT (1)	GT199600026A (de)
HN (1)	HN1996000017A (de)
HR (1)	HRP960216B1 (de)
HU (1)	HUP9900917A3 (de)
IL (1)	IL117859A (de)
MX (1)	MX9707948A (de)
MY (1)	MY118452A (de)
NO (1)	NO975496L (de)
NZ (1)	NZ307023A (de)
OA (1)	OA10745A (de)
PE (1)	PE55097A1 (de)
PL (1)	PL323683A1 (de)
PT (1)	PT828488E (de)
SK (1)	SK162297A3 (de)
SV (2)	SV1996000026A (de)
TW (1)	TW418206B (de)
UY (1)	UY24244A1 (de)
WO (1)	WO1996038144A1 (de)
ZA (1)	ZA964441B (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6001863A (en) *	1996-11-26	1999-12-14	Warner-Lambert Company	Isothiazolones
US6706729B1 (en)	1998-06-19	2004-03-16	The United States Of America As Represented By The Department Of Health And Human Services	Thiolesters and uses thereof
CA2335464A1 (en) *	1998-06-19	1999-12-23	Jim A. Turpin	Novel thiolesters and uses thereof
GEP20033045B (en)	1998-09-17	2003-08-25	Bristol Myers Squibb Co	Method for Treating Diabetes
GB9917406D0 (en)	1999-07-23	1999-09-22	Smithkline Beecham Plc	Compounds
GB9917408D0 (en)	1999-07-23	1999-09-22	Smithkline Beecham Plc	Compounds
TW591031B (en) *	2000-02-29	2004-06-11	Takeda Chemical Industries Ltd	Thienopyridine derivatives, their production and use
US6395767B2 (en)	2000-03-10	2002-05-28	Bristol-Myers Squibb Company	Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US6432433B1 (en)	2000-06-05	2002-08-13	Isp Investments Inc.	Liquid biocidal composition of a formaldehyde adduct and an isothiazolone and method of use
EP1305308B1 (de)	2000-07-26	2006-12-20	Smithkline Beecham Plc	Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
GB0101577D0 (en)	2001-01-22	2001-03-07	Smithkline Beecham Plc	Compounds
AU2002254567B2 (en)	2001-04-11	2007-10-11	Bristol-Myers Squibb Company	Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
KR20040054729A (ko)	2001-10-18	2004-06-25	브리스톨-마이어스 스큅 컴퍼니	인간 글루카곤-유사-펩티드-1 모방체, 및 당뇨병 및 이와관련된 증상의 치료에 있어서 이의 용도
US7238671B2 (en)	2001-10-18	2007-07-03	Bristol-Myers Squibb Company	Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
AU2002348276A1 (en)	2001-11-16	2003-06-10	Bristol-Myers Squibb Company	Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
AU2002367173A1 (en) *	2001-12-21	2003-07-15	Achillion Pharmaceuticals, Inc.	Antifungal compositions
US7101676B2 (en) *	2002-01-11	2006-09-05	Douglas Buechter	Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA
US7312212B2 (en)	2002-01-29	2007-12-25	Glaxo Group Limited	Aminopiperidine derivatives
KR100653017B1 (ko) *	2002-02-08	2006-12-01	에프. 호프만-라 로슈 아게	골 손실의 치료 및 예방 방법
GB0208223D0 (en) *	2002-04-10	2002-05-22	Celltech R&D Ltd	Chemical compounds
US7057046B2 (en)	2002-05-20	2006-06-06	Bristol-Myers Squibb Company	Lactam glycogen phosphorylase inhibitors and method of use
ATE469645T1 (de)	2002-10-23	2010-06-15	Bristol Myers Squibb Co	Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
US7098235B2 (en)	2002-11-14	2006-08-29	Bristol-Myers Squibb Co.	Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
TW200504021A (en)	2003-01-24	2005-02-01	Bristol Myers Squibb Co	Substituted anilide ligands for the thyroid receptor
US7459474B2 (en)	2003-06-11	2008-12-02	Bristol-Myers Squibb Company	Modulators of the glucocorticoid receptor and method
US6995183B2 (en)	2003-08-01	2006-02-07	Bristol Myers Squibb Company	Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
US7371759B2 (en)	2003-09-25	2008-05-13	Bristol-Myers Squibb Company	HMG-CoA reductase inhibitors and method
SG134333A1 (en)	2003-11-12	2007-08-29	Phenomix Corp	Heterocyclic boronic acid compounds
US7420059B2 (en)	2003-11-20	2008-09-02	Bristol-Myers Squibb Company	HMG-CoA reductase inhibitors and method
CN101798291A (zh) *	2003-12-29	2010-08-11	塞普拉科公司	苯并[d]异噁唑-3-醇DAAO抑制剂
AU2004312530A1 (en) *	2003-12-29	2005-07-21	Sepracor Inc.	Pyrrole and pyrazole DAAO inhibitors
US7145040B2 (en)	2004-07-02	2006-12-05	Bristol-Myers Squibb Co.	Process for the preparation of amino acids useful in the preparation of peptide receptor modulators
US7534763B2 (en)	2004-07-02	2009-05-19	Bristol-Myers Squibb Company	Sustained release GLP-1 receptor modulators
TW200611704A (en)	2004-07-02	2006-04-16	Bristol Myers Squibb Co	Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
EP1778220A1 (de)	2004-07-12	2007-05-02	Phenomix Corporation	Eingezwängte cyano-verbindungen
AR051446A1 (es)	2004-09-23	2007-01-17	Bristol Myers Squibb Co	Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
US7635699B2 (en)	2004-12-29	2009-12-22	Bristol-Myers Squibb Company	Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7589088B2 (en)	2004-12-29	2009-09-15	Bristol-Myers Squibb Company	Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7317024B2 (en)	2005-01-13	2008-01-08	Bristol-Myers Squibb Co.	Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US20060235028A1 (en)	2005-04-14	2006-10-19	Li James J	Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
JP2008540370A (ja) *	2005-05-04	2008-11-20	エフ．ホフマン−ラロシュアーゲー	ヘテロ環式抗ウイルス化合物
US7521557B2 (en)	2005-05-20	2009-04-21	Bristol-Myers Squibb Company	Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
US7888381B2 (en)	2005-06-14	2011-02-15	Bristol-Myers Squibb Company	Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
JP2009500425A (ja)	2005-07-06	2009-01-08	セプラコアインコーポレーテッド	エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
EP1943215A2 (de)	2005-10-31	2008-07-16	Brystol-Myers Squibb Company	Inhibitoren von dipeptidylpeptidase iv auf pyrrolidinyl-beta-aminoamidbasis und verfahren
US7464565B2 (en) *	2005-11-29	2008-12-16	Maytag Corporation	Rapid temperature change device for a refrigerator
US7592461B2 (en)	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
NZ569608A (en) *	2006-01-06	2011-09-30	Sepracor Inc	Tetralone-based monoamine reuptake inhibitors
BRPI0706365A2 (pt)	2006-01-06	2011-03-22	Sepracor Inc	Cicloalquilaminas como inibidores da recaptação de monoamina
DK2816024T3 (en)	2006-03-31	2017-10-30	Sunovion Pharmaceuticals Inc	CHIRALE AMINER
US7803778B2 (en)	2006-05-23	2010-09-28	Theracos, Inc.	Glucose transport inhibitors and methods of use
US20100022457A1 (en)	2006-05-26	2010-01-28	Bristol-Myers Squibb Company	Sustained release glp-1 receptor modulators
US7919598B2 (en)	2006-06-28	2011-04-05	Bristol-Myers Squibb Company	Crystal structures of SGLT2 inhibitors and processes for preparing same
US7884124B2 (en) *	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) *	2006-06-30	2009-08-25	Sepracor Inc.	Fused heterocycles
US7727978B2 (en)	2006-08-24	2010-06-01	Bristol-Myers Squibb Company	Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
US20080082066A1 (en) *	2006-10-02	2008-04-03	Weyerhaeuser Co.	Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
WO2008057862A2 (en)	2006-11-01	2008-05-15	Bristol-Myers Squibb Company	MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
WO2008057857A1 (en)	2006-11-01	2008-05-15	Bristol-Myers Squibb Company	MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
US7902252B2 (en) *	2007-01-18	2011-03-08	Sepracor, Inc.	Inhibitors of D-amino acid oxidase
US20090099248A1 (en) *	2007-01-18	2009-04-16	Sepracor Inc.	Inhibitors of d-amino acid oxidase
TW200904405A (en)	2007-03-22	2009-02-01	Bristol Myers Squibb Co	Pharmaceutical formulations containing an SGLT2 inhibitor
EP2142551B1 (de)	2007-04-17	2015-10-14	Bristol-Myers Squibb Company	KONDENSIERTE HETEROCYCLISCHE Verbindungen als Hemmer der BETA-HYDROXYSTEROID-DEHYDROGENASE -TYP I
PE20090696A1 (es)	2007-04-20	2009-06-20	Bristol Myers Squibb Co	Formas cristalinas de saxagliptina y procesos para preparar las mismas
ES2388315T3 (es)	2007-05-04	2012-10-11	Bristol-Myers Squibb Company	Agonistas [6,5]-bicíclicos de receptores GPR119 acoplados a la proteína G
US7910583B2 (en)	2007-05-04	2011-03-22	Bristol-Myers Squibb Company	[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
MX2009012678A (es) *	2007-05-25	2012-09-20	Vertex Pharma	Moduladores de canal de ion y metodos de uso.
AU2008259841B2 (en)	2007-05-31	2015-02-05	Sunovion Pharmaceuticals Inc.	Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
EA016595B1 (ru)	2007-07-17	2012-06-29	Бристол-Маерс Сквибб Компани	Способ модулирования рецептора gpr119, сопряженного с g-белком, и используемые при этом соединения
ES2408384T3 (es)	2007-07-27	2013-06-20	Bristol-Myers Squibb Company	Nuevos activadores de glucoquinasa y procedimientos de uso de los mismos
NZ583369A (en)	2007-08-23	2011-08-26	Theracos Inc	Benzylbenzene derivatives and methods of use
WO2009058944A2 (en)	2007-11-01	2009-05-07	Bristol-Myers Squibb Company	Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and /or nf- kappa b activity and use thereof
ES2402322T3 (es) *	2007-11-15	2013-04-30	Gilead Sciences, Inc.	Inhibidores de la replicación del virus de la inmunodeficiencia humana
ES2463720T3 (es) *	2007-11-16	2014-05-29	Gilead Sciences, Inc.	Inhibidores de la replicación del virus de inmunodeficiencia humana
AU2009270936B2 (en)	2008-07-15	2014-12-18	Theracos, Inc.	Deuterated benzylbenzene derivatives and methods of use
TW201006821A (en)	2008-07-16	2010-02-16	Bristol Myers Squibb Co	Pyridone and pyridazone analogues as GPR119 modulators
WO2010017418A1 (en) *	2008-08-07	2010-02-11	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
WO2011017634A2 (en) *	2009-08-07	2011-02-10	Sepracore Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
ES2689107T3 (es)	2009-11-13	2018-11-08	Astrazeneca Ab	Formulaciones de tabletas bicapa
WO2011060255A1 (en)	2009-11-13	2011-05-19	Bristol-Myers Squibb Company	Reduced mass metformin formulations
EP2498759B1 (de)	2009-11-13	2018-08-01	AstraZeneca AB	Tablettenformulierungen mit sofortiger freisetzung
TWI562775B (en)	2010-03-02	2016-12-21	Lexicon Pharmaceuticals Inc	Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
US20110257233A1 (en) *	2010-03-19	2011-10-20	Sanford-Burnham Medical Research Institute	Benzoisothiazolones as inhibitors of phosphomannose isomerase
SG184168A1 (en)	2010-04-08	2012-10-30	Bristol Myers Squibb Co	Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators
CN102971313A (zh)	2010-04-14	2013-03-13	百时美施贵宝公司	新颖的葡糖激酶激活剂及其使用方法
US8729084B2 (en)	2010-05-06	2014-05-20	Bristol-Myers Squibb Company	Benzofuranyl analogues as GPR119 modulators
US8940716B2 (en)	2010-05-06	2015-01-27	Bristol-Myers Squibb Company	Bicyclic heteroaryl compounds as GPR119 modulators
WO2011153712A1 (en)	2010-06-12	2011-12-15	Theracos, Inc.	Crystalline form of benzylbenzene sglt2 inhibitor
WO2012018950A1 (en)	2010-08-03	2012-02-09	Beth Israel Deaconess Medical Center	Methods and compositions for treatment of metabolic disorders
US9662328B2 (en)	2010-11-29	2017-05-30	National Yang-Ming University	Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells
TWI445696B (zh) *	2010-11-29	2014-07-21	Univ Nat Yang Ming	標靶人類胸線核苷酸激酶誘導惡性腫瘤中的ｄｎａ修復毒性
TWI631963B (zh)	2011-01-05	2018-08-11	雷西肯製藥股份有限公司	包含鈉－葡萄糖共同輸送體１與２之抑制劑的組合物與應用方法
WO2013173198A1 (en)	2012-05-16	2013-11-21	Bristol-Myers Squibb Company	Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators
US9200025B2 (en)	2012-11-20	2015-12-01	Lexicon Pharmaceuticals, Inc.	Inhibitors of sodium glucose cotransporter 1
CN103232842B (zh) *	2013-04-15	2015-11-18	山东大学	一种基于聚集诱导荧光增强材料的亚硫酸氢根离子的荧光探针及快速检验试纸
US9593113B2 (en)	2013-08-22	2017-03-14	Bristol-Myers Squibb Company	Imide and acylurea derivatives as modulators of the glucocorticoid receptor
WO2015061272A1 (en)	2013-10-22	2015-04-30	Bristol-Myers Squibb Company	Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
US20160046651A1 (en) *	2014-07-22	2016-02-18	Washington University	Treatment of malaria using inhibitors of the ispd enzyme in the non-mevalonate pathway
CN104230839A (zh) *	2014-09-25	2014-12-24	上海化学试剂研究所有限公司	一种n-取代苯并异噻唑啉酮衍生物的合成方法
US9925190B2 (en) *	2015-02-16	2018-03-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Small molecules targeting HIV-1 Nef
TW201702271A (zh)	2015-04-30	2017-01-16	哈佛大學校長及研究員協會	治療代謝病症之抗－ａｐ２抗體及抗原結合劑
JP7072557B2 (ja)	2016-07-22	2022-05-20	ブリストル－マイヤーズスクイブカンパニー	グルコキナーゼ活性化剤およびその使用方法
WO2019119673A1 (zh)	2017-12-19	2019-06-27	北京吉源生物科技有限公司	一种双基因修饰的干细胞及其用途
WO2019126567A1 (en) *	2017-12-22	2019-06-27	Southern Research Institute	Substituted heterocyclic-pyridinones as hiv-1 nef-hck inhibitors
WO2020038464A1 (zh)	2018-08-23	2020-02-27	北京厚燊药德科技有限责任公司	苯氧酸类化合物及其医药用途
US10968192B2 (en)	2018-09-26	2021-04-06	Lexicon Pharmaceuticals, Inc.	Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis
CN111253335B (zh) *	2020-03-12	2023-06-06	浙江扬帆新材料股份有限公司	一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE724034C (de) *	1938-11-04	1942-08-17	Algemeene Kunstvezel Mij N V	Verfahren zum Erzeugen farbiger Glasfasern
US3012039A (en) *	1958-03-14	1961-12-05	Ici Ltd	2-p-chlorobenzyl-1, 2-benzisothiazolone
US3517022A (en) *	1967-10-03	1970-06-23	Rohm & Haas	Certain 2-carbamoyl-1,2-benzisothiazolones
US3661974A (en) *	1970-04-27	1972-05-09	Sherwin Williams Co	2-carbalkoxy-phenyl sulfenamides
GB1306493A (en) *	1970-04-27	1973-02-14	Sherwin Williams Co	Aromatic sulphenamides the preparation thereof and cyclization thereof
US3761489A (en) *	1971-12-20	1973-09-25	Sherwin Williams Co	Substituted n-alkyl benzisothiazolinones
US4049817A (en) *	1972-08-14	1977-09-20	Sandoz Ltd.	Synergistic compositions
US3965107A (en) *	1974-07-08	1976-06-22	Rohm And Haas Company	Isothiazolopyridinones
IT1039699B (it) *	1975-07-03	1979-12-10	Prephar	Composizione spermicida a base di derivati benzisotiazolici
DE2602643C2 (de) *	1976-01-24	1984-12-20	Bayer Ag, 5090 Leverkusen	1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
GB1560726A (en) *	1976-04-28	1980-02-06	Beecham Group Ltd	Isothiazolo-pyridines
FR2492376A1 (fr) *	1980-10-17	1982-04-23	Cird	Polymethylene-4,5 isothiazoline-4 ones-3, leur procede de preparation et leurs utilisation comme agents bactericides et fongicides
DE3041036A1 (de) *	1980-10-31	1982-06-09	A. Nattermann & Cie GmbH, 5000 Köln	Verwendung von benzisothiazolen
US4458942A (en) *	1981-12-07	1984-07-10	American Seating Company	Three-quarter fold retracting chair
LU84091A1 (fr) *	1982-04-16	1984-03-02	Oreal	Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides
FR2555450B1 (fr) *	1983-11-24	1988-04-01	Oreal	Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3
FR2631028B1 (fr) *	1988-05-09	1990-07-13	Cird	Adamantyl-2 isothiazoline-4 ones-3, leur procede de preparation et leur utilisation comme agents bactericides et fongicides
US5405851A (en) *	1990-06-19	1995-04-11	Burroughs Wellcome Co.	Pharmaceutical compounds
JPH0477476A (ja) *	1990-07-19	1992-03-11	Sankyo Co Ltd	抗潰瘍剤
US5219875A (en) *	1990-11-27	1993-06-15	Rohm And Haas Company	Antimicrobial compositions comprising iodopropargyl butylcarbamate and 1,2-benzisothiazolin-3-one and methods of controlling microbes
NO304832B1 (no) *	1992-05-27	1999-02-22	Ube Industries	Aminokinolonderivater samt middel mot HIV
FR2695378B1 (fr) *	1992-09-10	1994-12-02	Aerospatiale	Dispositif à sangle pour le maintien temporaire d'objets ensemble.
RU2118322C1 (ru) *	1993-07-05	1998-08-27	Дюфар Интернэшнл Рисерч Б.В.	2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли

1995
- 1995-05-31 US US08/456,149 patent/US5620997A/en not_active Expired - Fee Related
- 1995-12-15 TW TW084113376A patent/TW418206B/zh not_active IP Right Cessation
- 1995-12-15 CO CO95059308A patent/CO4700292A1/es unknown
1996
- 1996-04-09 IL IL11785996A patent/IL117859A/xx not_active IP Right Cessation
- 1996-04-19 SV SV1996000026A patent/SV1996000026A/es unknown
- 1996-04-26 PL PL96323683A patent/PL323683A1/xx unknown
- 1996-04-26 CZ CZ973739A patent/CZ373997A3/cs unknown
- 1996-04-26 DE DE69626203T patent/DE69626203T2/de not_active Expired - Fee Related
- 1996-04-26 NZ NZ307023A patent/NZ307023A/en unknown
- 1996-04-26 AT AT96913177T patent/ATE232385T1/de not_active IP Right Cessation
- 1996-04-26 ES ES96913177T patent/ES2192224T3/es not_active Expired - Lifetime
- 1996-04-26 PT PT96913177T patent/PT828488E/pt unknown
- 1996-04-26 KR KR1019970708611A patent/KR19990022132A/ko not_active Abandoned
- 1996-04-26 HU HU9900917A patent/HUP9900917A3/hu unknown
- 1996-04-26 CN CN96194276A patent/CN1114402C/zh not_active Expired - Fee Related
- 1996-04-26 EA EA199700444A patent/EA000898B1/ru not_active IP Right Cessation
- 1996-04-26 KR KR10-2003-7011364A patent/KR20040004547A/ko not_active Ceased
- 1996-04-26 GE GEAP19964062A patent/GEP20012375B/en unknown
- 1996-04-26 AU AU55771/96A patent/AU723233B2/en not_active Ceased
- 1996-04-26 DK DK96913177T patent/DK0828488T3/da active
- 1996-04-26 EE EE9700287A patent/EE9700287A/xx unknown
- 1996-04-26 WO PCT/US1996/005821 patent/WO1996038144A1/en not_active Ceased
- 1996-04-26 CA CA002218253A patent/CA2218253A1/en not_active Abandoned
- 1996-04-26 EP EP96913177A patent/EP0828488B1/de not_active Expired - Lifetime
- 1996-04-26 SK SK1622-97A patent/SK162297A3/sk unknown
- 1996-04-26 MX MX9707948A patent/MX9707948A/es not_active IP Right Cessation
- 1996-04-26 JP JP53647396A patent/JP2002502353A/ja not_active Abandoned
- 1996-05-07 US US08/646,188 patent/US5668162A/en not_active Expired - Fee Related
- 1996-05-08 HR HR960216A patent/HRP960216B1/xx not_active IP Right Cessation
- 1996-05-15 AR ARP960102576A patent/AR002740A1/es not_active Application Discontinuation
- 1996-05-15 HN HN1996000017A patent/HN1996000017A/es unknown
- 1996-05-24 SV SV1996000033A patent/SV1996000033A/es not_active Application Discontinuation
- 1996-05-24 GT GT199600026A patent/GT199600026A/es unknown
- 1996-05-29 MY MYPI96002063A patent/MY118452A/en unknown
- 1996-05-30 PE PE1996000385A patent/PE55097A1/es not_active Application Discontinuation
- 1996-05-30 UY UY24244A patent/UY24244A1/es unknown
- 1996-05-30 ZA ZA964441A patent/ZA964441B/xx unknown
- 1996-11-26 US US08/757,716 patent/US5733921A/en not_active Expired - Fee Related
1997
- 1997-06-26 US US08/882,846 patent/US6133270A/en not_active Expired - Fee Related
- 1997-11-12 OA OA70126A patent/OA10745A/en unknown
- 1997-11-27 BG BG102077A patent/BG62792B1/bg unknown
- 1997-11-28 NO NO975496A patent/NO975496L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MX9707948A (es)	1997-12-31
KR19990022132A (ko)	1999-03-25
US5620997A (en)	1997-04-15
AU723233B2 (en)	2000-08-24
CA2218253A1 (en)	1996-12-05
ATE232385T1 (de)	2003-02-15
CZ373997A3 (cs)	1998-11-11
HUP9900917A3 (en)	2003-04-28
PT828488E (pt)	2003-06-30
MY118452A (en)	2004-11-30
IL117859A (en)	2000-07-16
PL323683A1 (en)	1998-04-14
HUP9900917A2 (hu)	1999-09-28
BG102077A (en)	1998-11-30
GT199600026A (es)	1997-11-15
UY24244A1 (es)	2001-10-25
NO975496D0 (no)	1997-11-28
SK162297A3 (en)	2000-04-10
HRP960216A2 (en)	1997-08-31
DE69626203D1 (en)	2003-03-20
SV1996000033A (es)	1998-01-29
US5668162A (en)	1997-09-16
NO975496L (no)	1998-01-22
AR002740A1 (es)	1998-04-29
US6133270A (en)	2000-10-17
GEP20012375B (en)	2001-03-25
CN1185737A (zh)	1998-06-24
AU5577196A (en)	1996-12-18
DE69626203T2 (de)	2003-11-20
EA000898B1 (ru)	2000-06-26
EP0828488B1 (de)	2003-02-12
PE55097A1 (es)	1998-01-16
WO1996038144A1 (en)	1996-12-05
HN1996000017A (es)	2000-03-24
TW418206B (en)	2001-01-11
ZA964441B (en)	1996-12-10
CO4700292A1 (es)	1998-12-29
OA10745A (en)	2002-12-10
BG62792B1 (bg)	2000-08-31
EP0828488A1 (de)	1998-03-18
CN1114402C (zh)	2003-07-16
JP2002502353A (ja)	2002-01-22
EA199700444A1 (ru)	1998-06-25
IL117859A0 (en)	1996-08-04
KR20040004547A (ko)	2004-01-13
US5733921A (en)	1998-03-31
ES2192224T3 (es)	2003-10-01
EE9700287A (et)	1998-06-15
HRP960216B1 (en)	2001-12-31
SV1996000026A (es)	1997-03-05
NZ307023A (en)	2001-03-30

Publication	Publication Date	Title
DK0828488T3 (da)	2003-05-19	Isothiazoloner
DE69608259D1 (de)	2000-06-15	Verbunddamenbinde
ATA135896A (de)	2001-02-15	Skibob
ATE198470T1 (de)	2001-01-15	Alkenyl-benzoylguanidine
ATE240972T1 (de)	2003-06-15	Cyclopeptolide
ATA119896A (de)	2002-04-15	Scheibenmähwerk
BR9609863A (pt)	1999-03-16	Fecho
DE69528463D1 (de)	2002-11-07	Polyphenylencopolymere
BR9501643A (pt)	1997-09-16	Helistato
SE9501817D0 (sv)	1995-05-17	När/långsyntssimdykningsglasögon
KR960030307U (ko)	1996-10-22	다시
FI1955U1 (fi)	1995-06-14	Tryckreduceringsventil
FI2063U1 (fi)	1995-08-22	Foerpackningsaemne
BR7500991U (pt)	1996-06-18	Caríndio
BR7501376U (pt)	1997-09-16	Massarreal
BR7500809U (pt)	1997-05-13	Tele-negocios
BR7500825U (pt)	1997-05-13	Chutegol
BR7500838U (pt)	1997-05-13	Vassourágua
FI956315A0 (fi)	1995-12-29	Peseytymiskaluste
KR970008463U (ko)	1997-03-27	클리어파일
FI954792A0 (fi)	1995-10-09	Varmluftsmotor
BR7501298U (pt)	1997-09-16	Torre-audio-visual
BR7501299U (pt)	1997-09-16	Geladeira-prática
BR7501301U (pt)	1997-09-16	Guarda-chuva-mochila
FI951786A0 (fi)	1995-04-13	Kylturbin